Guard Therapeutics (Sweden) Today

GUARD Stock  SEK 18.70  0.70  3.89%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Over 64

 
100  
 
Zero
Quite High
Guard Therapeutics is selling for under 18.70 as of the 28th of March 2024; that is 3.89 percent up since the beginning of the trading day. The stock's lowest day price was 17.7. Guard Therapeutics has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Guard Therapeutics International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of June 2022 and ending today, the 28th of March 2024. Click here to learn more.
Guard Therapeutics International AB , a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. Guard Therapeutics International AB was incorporated in 2008 and is based in Stockholm, Sweden. The company has 503.08 M outstanding shares. More on Guard Therapeutics International

Moving against Guard Stock

  0.81SEB-A Skandinaviska EnskildaPairCorr
  0.81SHB-B Svenska HandelsbankenPairCorr
  0.75SHB-A Svenska HandelsbankenPairCorr
  0.64ATCO-B Atlas Copco ABPairCorr
  0.63VOLV-A AB VolvoPairCorr
  0.62VOLV-B AB VolvoPairCorr
  0.58ATCO-A Atlas Copco ABPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Guard Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Guard Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Guard Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chief Executive OfficerTobias Agervald
Business ConcentrationHealth Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Guard Therapeutics International (GUARD) is traded on Stockholm Exchange in Sweden and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 624.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guard Therapeutics's market, we take the total number of its shares issued and multiply it by Guard Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guard Therapeutics operates under Biotechnology sector and is part of Health Care industry. The entity has 503.08 M outstanding shares. Guard Therapeutics International has accumulated about 188.6 M in cash with (77.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Guard Therapeutics Probability Of Bankruptcy
Ownership Allocation
Guard Therapeutics secures a total of 503.08 Million outstanding shares. Guard Therapeutics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Guard Ownership Details

Guard Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Guard Therapeutics jumping above the current price in 90 days from now is about 78.17%. The Guard Therapeutics International probability density function shows the probability of Guard Therapeutics stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 2.2778. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Guard Therapeutics will likely underperform. Additionally, guard Therapeutics International has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 18.7HorizonTargetOdds Above 18.7
21.77%90 days
 18.70 
78.17%
Based on a normal probability distribution, the odds of Guard Therapeutics to move above the current price in 90 days from now is about 78.17 (This Guard Therapeutics International probability density function shows the probability of Guard Stock to fall within a particular range of prices over 90 days) .

Guard Therapeutics Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Guard Therapeutics market risk premium is the additional return an investor will receive from holding Guard Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Guard Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Guard Therapeutics' alpha and beta are two of the key measurements used to evaluate Guard Therapeutics' performance over the market, the standard measures of volatility play an important role as well.

Guard Stock Against Markets

Picking the right benchmark for Guard Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Guard Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Guard Therapeutics is critical whether you are bullish or bearish towards Guard Therapeutics International at a given time. Please also check how Guard Therapeutics' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Guard Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Guard Therapeutics Corporate Management

Elected by the shareholders, the Guard Therapeutics' board of directors comprises two types of representatives: Guard Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guard. The board's role is to monitor Guard Therapeutics' management team and ensure that shareholders' interests are well served. Guard Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guard Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Cristina GladChairman of the BoardProfile
Fredrik LehmannAdvisor in CMC (Chemistry Manufacturing and Controls)Profile
Sara ThuressonHead OperationsProfile
Johannes HultheDirectorProfile
AnnKristin MydeHead - Global Project ManagementProfile
Elisabeth AugustssonAdvisor in Regulatory AffairsProfile

How to buy Guard Stock?

Before investing in Guard Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Guard Therapeutics. To buy Guard Therapeutics stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Guard Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Guard Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Guard Therapeutics International stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Guard Therapeutics International stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Guard Therapeutics International, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Guard Therapeutics International?

The danger of trading Guard Therapeutics International is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Guard Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Guard Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Guard Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guard Therapeutics International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Guard Therapeutics information on this page should be used as a complementary analysis to other Guard Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Guard Stock analysis

When running Guard Therapeutics' price analysis, check to measure Guard Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guard Therapeutics is operating at the current time. Most of Guard Therapeutics' value examination focuses on studying past and present price action to predict the probability of Guard Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guard Therapeutics' price. Additionally, you may evaluate how the addition of Guard Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Please note, there is a significant difference between Guard Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Guard Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guard Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.